buy mad cat now!
6-(2-aminopropyl)benzofuran or 1-benzofuran-6-ylpropan-2-amine (6-APB or Benzo Fury) is a stimulant and entactogen drug . It was first identified being sold as a designer drug in 2011, and again in 2012. Chemically, it is of the phenethylamine and substituted amphetamine classes. It is similar to MDA in that the 3,4-methylenedioxyphenyl ring system has been replaced with a benzofuran ring. 6-APB is also the unsaturated benzofuran derivative of 6-APDB. There is currently no toxicology data available.
6-APB has not been properly assessed in terms of pharmacological action, but based on its chemical similarity to other amphetamines and methylenedioxy compounds, it likely acts as a releasing agent and reuptake inhibitor of serotonin, norepinephrine, and dopamine. Though its effects on monoamine release have not been validated, 6-APB has been claimed to act as an agonist of the 5-HT2C receptor. It may also act as an agonist of the 5-HT2A and 5-HT2B receptors, the former likely explaining its reputed psychedelic effects.
6-APB is unscheduled in the United States. However, this chemical may be covered under the Federal Analogue Act in the United States.
Certain countries contain a "substantially similar" catch-all clause in their drug law, such as New Zealand and Australia. This includes 6-APB as it is in some respects similar in chemical structure to the class A drug MDA, meaning 6-APB may be viewed as a controlled substance analogue in these jurisdictions.
6-APB is unscheduled under the Controlled Drugs and Substances Act (CDSA) in Canada, although there is a Schedule III amphetamine analogue clause. Due to 6-APB's structure, it may be considered an analogue of MDA, but these types of offenses are rarely prosecuted. Canada's CDSA defines an analogue as any substance that, in relation to a controlled substance, has a substantially similar chemical structure.
6-APB is currently legal in the United Kingdom.
|Systematic (IUPAC) name|
|CAS number|| |
|Mol. mass||175.23 g/mol|